Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-07-25
1991-11-12
Rollins, John W.
Drug, bio-affecting and body treating compositions
Lymphokine
514 56, 514814, 514822, A61K 31745, A61K 31725
Patent
active
050646435
ABSTRACT:
In accordance with the present invention, a method is provided for treating sickle cell anemia. The method comprises injecting an effective concentration of a surface active copolymer into the patient with sickle cell anemia.
The surface active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula:
REFERENCES:
patent: Re29909 (1979-02-01), Kurtz
patent: 3450502 (1968-06-01), Hymes
patent: 3577522 (1971-05-01), Hymes
patent: 3590125 (1971-06-01), Hymes
patent: 3641240 (1972-02-01), Hymes
patent: 3740421 (1973-06-01), Schmolka
patent: 3956259 (1976-05-01), Garcia
patent: 4073886 (1978-02-01), Kehm
patent: 4179337 (1979-12-01), Davis
patent: 4186253 (1980-01-01), Yokoyama
patent: 4305922 (1981-12-01), Rhodes
patent: 4600652 (1986-07-01), Solomon
patent: 4609546 (1986-09-01), Hiratani
Smith, et al., "Pluronic F-68, a Non-Ionic Emulsifier, Reduces the Adhesivity of Liganded Sickle Erythrocytes", Sixth International Congress of Biorheology, Vancouver, B.C. Canada, Jul. 27 through Aug. 1, 1986, Biorheology, vol. 23, No. 3, p. 238, 1986.
Geyer, R. P., "Potential Uses of Artificial Blood Substitutes", Federation Proceedings, vol. 34, No. 6, pp. 1525 through 1528, 1975.
Padilla, et al., "Effect of Fluorocarbon Emulsions on the Viscosity of Normal and Sickle Cells", in Blood Substutes and Plasma Expanders, pp. 61 through 68. Alan R. Liss, Inc. New York, N.Y. 1978.
Schmolka, I., "A Review Of Block Polymer Surfactants", Journal of the American Oil Chemists Society, 54, No. 3, pp. 110-116 (1977).
Block and Graft Copolymerization, vol. 2, (ed. by R. J. Ceresa, John Wiley & Sons, 1976) "The Applications of Block Copolymer Polyol Surfactants", L. G. Lundsted and I. R. Schmolka; pp. 174 through 205 and pp. 225 through 272 (references).
Reindorf, C. A., "Perfluorocarbon Compounds: Effects on the Rheological Properties of Sickle Erthrocytes in Vitro", American Journal of Hermatology, vol. 19, pp. 229-236 (1985).
Vercellotte, G. M., "Activation of Plasma Complement by Perfluorocarbon Artificial Blood: Probable Mechanism of Adverse Pulmonary Reactions in Treated Patients and Rationale for Corticosteroid Prophylaxis", Blood, vol. 59, pp. 299-1304 (1982).
Rodeheaver, G. T., "Pluronic F-68: A Promising New Skin Wound Cleanser", Ann Emerg Med., pp.572-576 (1980).
Padilla, F., et al., "Effect of Fluorocarbon Emulsions on the Mechanical Fragility of Normal and Sickle Cells: in Vitro Studies", Federation Proceedings, vol. 34, pp. 1510-1512 (1975).
Janoff, A. S., et al., "The Modification of Human Erthrocyte Membrane Structure by Membrane Stabilizers: An Electron Spin Resonance Study", American Journal of Hematology vol. 10 pp. 171-179 (1981).
Moore, A. R., et al, "Reduction of Splenic Vascular Resistance During Profusion By Pluronic F-68", Journal of Surgical Research, vol. 8, No. 12, pp. 563-566, (1968).
Benner, K. U. et al., "Cold-Induced Platelet Aggregation In Vivo And Its Inhibition By A Nonionic Surface Active Substance", Thrombosis Research, vol. 2, pp. 331-342, (1973).
Hymes, A. C., "The Influence Of An Industrial Surfactant Pluronic F-68, In The Treatment of Hemorrhagic Shock", Journal of Surgical Research, vol. 11, pp. 191-197, (1971).
Hoie, J., "Effects of Pluronic F68, Poloxalkol, On Vascular Resistance In Vivo", Journal of Surgical Research, vol. 11, pp. 515-517, (1971).
Grover, F. L. et al., "A Nonionic Surfactant and Blood Viscosity", Arch. Surg., vol. 106, pp. 307-310, (1973).
Grover, Frederick L. et al., "The Effect of Pluronic F-68 On Circulatory Dynamics And Renal And Carotid Artery Flow During Hemorrhagic Shock", Journal of Surgical Research vol. 17, pp. 30-35, (1974).
Ketchum, Lynn D. et al, "Pharmacological Alterations in the Clotting Mechanism: Use in Microvascular Surgery", Journal of Hand Surgery, vol. 3, pp. 407-415, (1978).
Ketchum, Lynn D. et al., "Experimental Use Of Pluronic.RTM. F-68 In Microvascular Surgery", Plastic and Reconstructive Surgery, vol. 53, pp. 288-292, (1974).
Vasco, K. A., et al., "Poloxalkol.RTM. (Pluronic F-68): A Priming Solution for Cardiopulmonary Bypass", Trans. Am. Soc. Artif. Int. Organs, 18, 526-531 (1972).
Block, N. L., et al., "Acutely Traumatized Canine Ureter, Effects of Low Molecular Weight Dextran and Surfactant Pluronic F-68", Urology, vol. III 190-194, (1974).
Knize, D. M., "Use of Antisludging Agents in Experimental Cold Injuries", Surgery, Gynecology & Obstetrics, vol. 129, pp. 1019-1026, (1969).
Technical bulletin entitled "Performance Chemicals".
Technical bulletin entitled "Pluronic.RTM. Block Copolymer Surfactants".
Perfluorochemical Blood Substitutes, Technical Information Ser. No. 5, Jun. 30, 1978, Revised, Jul. 1, 1981, Manufacturer: The Green Cross Corporation.
The Patent Cooperation Treaty International search report for PCT patent application No. PCT/US87/01067.
Patent Cooperation Treaty International Search Report for the PCT Patent Application No. PCT/US87/01747.
Duncan Alexander
Hunter Robert L.
Emory University
Rollins John W.
LandOfFree
Method for treating sickle cell disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating sickle cell disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating sickle cell disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1011990